Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Professor J. Watrin; 1887-1955.

Annales de dermatologie et de syphiligraphie

BEUREY J, JEANDIDIER P.
PMID: 13292791
Ann Dermatol Syphiligr (Paris). 1955 Nov-Dec;82(6):601-3.

No abstract available.

Cite
BEUREY J, JEANDIDIER P. Le Professeur J. Watrin; 1887-1955. Professor J. Watrin; 1887-1955. Ann Dermatol Syphiligr (Paris). 1955;82(6):601-3
BEUREY, J., & JEANDIDIER, P. (1955). Le Professeur J. Watrin; 1887-1955. Professor J. Watrin; 1887-1955. Annales de dermatologie et de syphiligraphie, 82(6), 601-3.
BEUREY, J, and JEANDIDIER, P. "Le Professeur J. Watrin; 1887-1955." Professor J. Watrin; 1887-1955. Annales de dermatologie et de syphiligraphie vol. 82,6 (1955): 601-3.
BEUREY J, JEANDIDIER P. Le Professeur J. Watrin; 1887-1955. Professor J. Watrin; 1887-1955. Ann Dermatol Syphiligr (Paris). 1955 Nov-Dec;82(6):601-3. French. PMID: 13292791.
Copy Download .nbib Format: NLM
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism

Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E.
PMID: 34813929
Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21.

Type 1 diabetes mellitus (T1DM) is associated with a high risk of cardiovascular (CV) complications, even after controlling for traditional CV risk factors. Therefore, determinants of the residual increased CV morbidity and mortality remain to be discovered. This prospective...

Cite
Riveline JP, Vergés B, Detournay B, et al. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021;48(3):101306doi: 10.1016/j.diabet.2021.101306.
Riveline, J. P., Vergés, B., Detournay, B., Picard, S., Benhamou, P. Y., Bismuth, E., Bordier, L., Jeandidier, N., Joubert, M., Roussel, R., Sola-Gazagnes, A., Bonnefond, A., Clavel, S., Velayoudom, F. L., Beltrand, J., Hanaire, H., Fontaine, P., Thivolet, C., Servy, H., Tubiana, S., Lion, S., Gautier, J. F., Larger, E., Vicaut, E., Sablone, L., Fagherazzi, G., & Cosson, E. (2021). Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes & metabolism, 48(3), 101306. https://doi.org/10.1016/j.diabet.2021.101306
Riveline, J P, et al. "Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study." Diabetes & metabolism vol. 48,3 (2021): 101306. doi: https://doi.org/10.1016/j.diabet.2021.101306
Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21. PMID: 34813929.
Copy Download .nbib Format: NLM
[The false debate about false emergencies].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Dollon C, Gaudelus J, Jeandidier B, Laborde H, Paries J.
PMID: 10370571
Arch Pediatr. 1999;6:464s-466s. doi: 10.1016/s0929-693x(99)80503-x.

No abstract available.

Cite
Dollon C, Gaudelus J, Jeandidier B, et al. Le faux débat des fausses urgences. [The false debate about false emergencies]. Arch Pediatr. 1999;6:464s-466sdoi: 10.1016/s0929-693x(99)80503-x.
Dollon, C., Gaudelus, J., Jeandidier, B., Laborde, H., & Paries, J. (1999). Le faux débat des fausses urgences. [The false debate about false emergencies]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 6464s-466s. https://doi.org/10.1016/s0929-693x(99)80503-x
Dollon, C, et al. "Le faux débat des fausses urgences." [The false debate about false emergencies]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 6 (1999): 464s-466s. doi: https://doi.org/10.1016/s0929-693x(99)80503-x
Dollon C, Gaudelus J, Jeandidier B, Laborde H, Paries J. Le faux débat des fausses urgences. [The false debate about false emergencies]. Arch Pediatr. 1999;6:464s-466s. doi: 10.1016/s0929-693x(99)80503-x. French. PMID: 10370571.
Copy Download .nbib Format: NLM
Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Joubert M, Meyer L, Doriot A, Dreves B, Jeandidier N, Reznik Y.
PMID: 34028700
Diabetes Ther. 2021 Jul;12(7):1809-1820. doi: 10.1007/s13300-021-01082-2. Epub 2021 May 24.

INTRODUCTION: Smartphone applications (apps) have been designed that help patients to accurately count their carbohydrate intake in order to optimize prandial insulin dose matching. Our aim was to evaluate the accuracy of two carbohydrate (carb) counting apps.METHODS: Medical students,...

Cite
Joubert M, Meyer L, Doriot A, et al. Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications. Diabetes Ther. 2021;12(7):1809-1820doi: 10.1007/s13300-021-01082-2.
Joubert, M., Meyer, L., Doriot, A., Dreves, B., Jeandidier, N., & Reznik, Y. (2021). Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(7), 1809-1820. https://doi.org/10.1007/s13300-021-01082-2
Joubert, Michael, et al. "Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 12,7 (2021): 1809-1820. doi: https://doi.org/10.1007/s13300-021-01082-2
Joubert M, Meyer L, Doriot A, Dreves B, Jeandidier N, Reznik Y. Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications. Diabetes Ther. 2021 Jul;12(7):1809-1820. doi: 10.1007/s13300-021-01082-2. Epub 2021 May 24. PMID: 34028700; PMCID: PMC8266981.
Copy Download .nbib Format: NLM
The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.

Cancers

M'kacher R, Cuceu C, Al Jawhari M, Morat L, Frenzel M, Shim G, Lenain A, Hempel WM, Junker S, Girinsky T, Colicchio B, Dieterlen A, Heidingsfelder L, Borie C, Oudrhiri N, Bennaceur-Griscelli A, Moralès O, Renaud S, Van de Wyngaert Z, Jeandidier E, Delhem N, Carde P.
PMID: 29848986
Cancers (Basel). 2018 May 30;10(6). doi: 10.3390/cancers10060169.

No abstract available.

Cite
M'kacher R, Cuceu C, Al Jawhari M, et al. The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes. Cancers (Basel). 2018;10(6)doi: 10.3390/cancers10060169.
M'kacher, R., Cuceu, C., Al Jawhari, M., Morat, L., Frenzel, M., Shim, G., Lenain, A., Hempel, W. M., Junker, S., Girinsky, T., Colicchio, B., Dieterlen, A., Heidingsfelder, L., Borie, C., Oudrhiri, N., Bennaceur-Griscelli, A., Moralès, O., Renaud, S., Van de Wyngaert, Z., Jeandidier, E., Delhem, N., & Carde, P. (2018). The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes. Cancers, 10(6), . https://doi.org/10.3390/cancers10060169
M'kacher, Radhia, et al. "The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes." Cancers vol. 10,6 (2018). doi: https://doi.org/10.3390/cancers10060169
M'kacher R, Cuceu C, Al Jawhari M, Morat L, Frenzel M, Shim G, Lenain A, Hempel WM, Junker S, Girinsky T, Colicchio B, Dieterlen A, Heidingsfelder L, Borie C, Oudrhiri N, Bennaceur-Griscelli A, Moralès O, Renaud S, Van de Wyngaert Z, Jeandidier E, Delhem N, Carde P. The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes. Cancers (Basel). 2018 May 30;10(6). doi: 10.3390/cancers10060169. PMID: 29848986; PMCID: PMC6025489.
Copy Download .nbib Format: NLM
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism

Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E.
PMID: 34813929
Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21.

Type 1 diabetes mellitus (T1DM) is associated with a high risk of cardiovascular (CV) complications, even after controlling for traditional CV risk factors. Therefore, determinants of the residual increased CV morbidity and mortality remain to be discovered. This prospective...

Cite
Riveline JP, Vergés B, Detournay B, et al. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021;48(3):101306doi: 10.1016/j.diabet.2021.101306.
Riveline, J. P., Vergés, B., Detournay, B., Picard, S., Benhamou, P. Y., Bismuth, E., Bordier, L., Jeandidier, N., Joubert, M., Roussel, R., Sola-Gazagnes, A., Bonnefond, A., Clavel, S., Velayoudom, F. L., Beltrand, J., Hanaire, H., Fontaine, P., Thivolet, C., Servy, H., Tubiana, S., Lion, S., Gautier, J. F., Larger, E., Vicaut, E., Sablone, L., Fagherazzi, G., & Cosson, E. (2021). Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes & metabolism, 48(3), 101306. https://doi.org/10.1016/j.diabet.2021.101306
Riveline, J P, et al. "Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study." Diabetes & metabolism vol. 48,3 (2021): 101306. doi: https://doi.org/10.1016/j.diabet.2021.101306
Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21. PMID: 34813929.
Copy Download .nbib Format: NLM
Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet.

Diabetology & metabolic syndrome

Auberval N, Dal S, Bietiger W, Pinget M, Jeandidier N, Maillard-Pedracini E, Schini-Kerth V, Sigrist S.
PMID: 25960774
Diabetol Metab Syndr. 2014 Nov 28;6:130. doi: 10.1186/1758-5996-6-130. eCollection 2014.

BACKGROUND: Metabolic syndrome is associated with an increased risk of cardiovascular and hepatic complications. Oxidative stress in metabolic tissues has emerged as a universal feature of metabolic syndrome and its co-morbidities. We aimed to develop a rapidly and easily...

Cite
Auberval N, Dal S, Bietiger W, et al. Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet. Diabetol Metab Syndr. 2014;6:130doi: 10.1186/1758-5996-6-130.
Auberval, N., Dal, S., Bietiger, W., Pinget, M., Jeandidier, N., Maillard-Pedracini, E., Schini-Kerth, V., & Sigrist, S. (2014). Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet. Diabetology & metabolic syndrome, 6130. https://doi.org/10.1186/1758-5996-6-130
Auberval, Nathalie, et al. "Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet." Diabetology & metabolic syndrome vol. 6 (2014): 130. doi: https://doi.org/10.1186/1758-5996-6-130
Auberval N, Dal S, Bietiger W, Pinget M, Jeandidier N, Maillard-Pedracini E, Schini-Kerth V, Sigrist S. Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet. Diabetol Metab Syndr. 2014 Nov 28;6:130. doi: 10.1186/1758-5996-6-130. eCollection 2014. PMID: 25960774; PMCID: PMC4424531.
Copy Download .nbib Format: NLM
Erratum: Cuceu, C., et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. .

Cancers

Cuceu C, Colicchio B, Jeandidier E, Junker S, Plassa F, Shim G, Mika J, Frenzel M, Al Jawhari M, Hempel WM, Kabacik S, Lenain A, Morat L, Girinsky T, Dieterlen A, Polanska J, Badie C, Carde P, M'Kacher R.
PMID: 31151278
Cancers (Basel). 2019 May 30;11(6). doi: 10.3390/cancers11060757.

The authors wish to make the following corrections to this paper [...].

Cite
Cuceu C, Colicchio B, Jeandidier E, et al. Erratum: Cuceu, C., et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. . Cancers (Basel). 2019;11(6)doi: 10.3390/cancers11060757.
Cuceu, C., Colicchio, B., Jeandidier, E., Junker, S., Plassa, F., Shim, G., Mika, J., Frenzel, M., Al Jawhari, M., Hempel, W. M., Kabacik, S., Lenain, A., Morat, L., Girinsky, T., Dieterlen, A., Polanska, J., Badie, C., Carde, P., & M'Kacher, R. (2019). Erratum: Cuceu, C., et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. . Cancers, 11(6), . https://doi.org/10.3390/cancers11060757
Cuceu, Corina, et al. "Erratum: Cuceu, C., et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. ." Cancers vol. 11,6 (2019). doi: https://doi.org/10.3390/cancers11060757
Cuceu C, Colicchio B, Jeandidier E, Junker S, Plassa F, Shim G, Mika J, Frenzel M, Al Jawhari M, Hempel WM, Kabacik S, Lenain A, Morat L, Girinsky T, Dieterlen A, Polanska J, Badie C, Carde P, M'Kacher R. Erratum: Cuceu, C., et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. . Cancers (Basel). 2019 May 30;11(6). doi: 10.3390/cancers11060757. PMID: 31151278; PMCID: PMC6627774.
Copy Download .nbib Format: NLM
Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability .

Cancers

Cuceu C, Colicchio B, Jeandidier E, Junker S, Plassa F, Shim G, Mika J, Frenzel M, Al Jawhari M, Hempel WM, O'Brien G, Lenain A, Morat L, Girinsky T, Dieterlen A, Polanska J, Badie C, Carde P, M'Kacher R.
PMID: 30011886
Cancers (Basel). 2018 Jul 13;10(7). doi: 10.3390/cancers10070233.

No abstract available.

Cite
Cuceu C, Colicchio B, Jeandidier E, et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability . Cancers (Basel). 2018;10(7)doi: 10.3390/cancers10070233.
Cuceu, C., Colicchio, B., Jeandidier, E., Junker, S., Plassa, F., Shim, G., Mika, J., Frenzel, M., Al Jawhari, M., Hempel, W. M., O'Brien, G., Lenain, A., Morat, L., Girinsky, T., Dieterlen, A., Polanska, J., Badie, C., Carde, P., & M'Kacher, R. (2018). Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability . Cancers, 10(7), . https://doi.org/10.3390/cancers10070233
Cuceu, Corina, et al. "Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability ." Cancers vol. 10,7 (2018). doi: https://doi.org/10.3390/cancers10070233
Cuceu C, Colicchio B, Jeandidier E, Junker S, Plassa F, Shim G, Mika J, Frenzel M, Al Jawhari M, Hempel WM, O'Brien G, Lenain A, Morat L, Girinsky T, Dieterlen A, Polanska J, Badie C, Carde P, M'Kacher R. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability . Cancers (Basel). 2018 Jul 13;10(7). doi: 10.3390/cancers10070233. PMID: 30011886; PMCID: PMC6071189.
Copy Download .nbib Format: NLM
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial.

JMIR research protocols

Jeandidier N, Chaillous L, Franc S, Benhamou PY, Schaepelynck P, Hanaire H, Catargi B, Farret A, Fontaine P, Guerci B, Reznik Y, Penfornis A, Borot S, Serusclat P, Kherbachi Y, D'Orsay G, Detournay B, Simon P, Charpentier G.
PMID: 29674306
JMIR Res Protoc. 2018 Apr 19;7(4):e66. doi: 10.2196/resprot.9154.

BACKGROUND: Self-management of diabetes minimizes the risk of macrovascular and microvascular complications, but understanding and/or adherence to self-management recommendations is often suboptimal. DIABEO is a smartphone app (downloaded via the internet) used to calculate bolus insulin doses. A previous...

Cite
Jeandidier N, Chaillous L, Franc S, et al. DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR Res Protoc. 2018;7(4):e66doi: 10.2196/resprot.9154.
Jeandidier, N., Chaillous, L., Franc, S., Benhamou, P. Y., Schaepelynck, P., Hanaire, H., Catargi, B., Farret, A., Fontaine, P., Guerci, B., Reznik, Y., Penfornis, A., Borot, S., Serusclat, P., Kherbachi, Y., D'Orsay, G., Detournay, B., Simon, P., & Charpentier, G. (2018). DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR research protocols, 7(4), e66. https://doi.org/10.2196/resprot.9154
Jeandidier, Nathalie, et al. "DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial." JMIR research protocols vol. 7,4 (2018): e66. doi: https://doi.org/10.2196/resprot.9154
Jeandidier N, Chaillous L, Franc S, Benhamou PY, Schaepelynck P, Hanaire H, Catargi B, Farret A, Fontaine P, Guerci B, Reznik Y, Penfornis A, Borot S, Serusclat P, Kherbachi Y, D'Orsay G, Detournay B, Simon P, Charpentier G. DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR Res Protoc. 2018 Apr 19;7(4):e66. doi: 10.2196/resprot.9154. PMID: 29674306; PMCID: PMC5934533.
Copy Download .nbib Format: NLM
High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications.

Nutrition & metabolism

Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, Jeandidier N, Maillard E, Marchioni E, Sigrist S, Dal S.
PMID: 26918024
Nutr Metab (Lond). 2016 Feb 25;13:15. doi: 10.1186/s12986-016-0074-1. eCollection 2016.

BACKGROUND: As a result of the increased consumption of sugar-rich and fatty-products, and the increase in preference for such products, metabolic disorders are becoming more common at a younger age. Fructose is particularly used in prepared foods and carbonated...

Cite
Lozano I, Van der Werf R, Bietiger W, et al. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond). 2016;13:15doi: 10.1186/s12986-016-0074-1.
Lozano, I., Van der Werf, R., Bietiger, W., Seyfritz, E., Peronet, C., Pinget, M., Jeandidier, N., Maillard, E., Marchioni, E., Sigrist, S., & Dal, S. (2016). High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutrition & metabolism, 1315. https://doi.org/10.1186/s12986-016-0074-1
Lozano, Iona, et al. "High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications." Nutrition & metabolism vol. 13 (2016): 15. doi: https://doi.org/10.1186/s12986-016-0074-1
Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, Jeandidier N, Maillard E, Marchioni E, Sigrist S, Dal S. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond). 2016 Feb 25;13:15. doi: 10.1186/s12986-016-0074-1. eCollection 2016. PMID: 26918024; PMCID: PMC4766713.
Copy Download .nbib Format: NLM
Practical implementation of automated closed-loop insulin delivery: A French position statement.

Diabetes & metabolism

Tubiana-Rufi N, Schaepelynck P, Franc S, Chaillous L, Joubert M, Renard E, Reznik Y, Abettan C, Bismuth E, Beltrand J, Bonnemaison E, Borot S, Charpentier G, Delemer B, Desserprix A, Durain D, Farret A, Filhol N, Guerci B, Guilhem I, Guillot C, Jeandidier N, Lablanche S, Leroy R, Melki V, Munch M, Penfornis A, Picard S, Place J, Riveline JP, Serusclat P, Sola-Gazagnes A, Thivolet C, Hanaire H, Benhamou PY.
PMID: 33152550
Diabetes Metab. 2021 May;47(3):101206. doi: 10.1016/j.diabet.2020.10.004. Epub 2020 Nov 02.

Automated closed-loop (CL) insulin therapy has come of age. This major technological advance is expected to significantly improve the quality of care for adults, adolescents and children with type 1 diabetes. To improve access to this innovation for both...

Cite
Tubiana-Rufi N, Schaepelynck P, Franc S, et al. Practical implementation of automated closed-loop insulin delivery: A French position statement. Diabetes Metab. 2020;47(3):101206doi: 10.1016/j.diabet.2020.10.004.
Tubiana-Rufi, N., Schaepelynck, P., Franc, S., Chaillous, L., Joubert, M., Renard, E., Reznik, Y., Abettan, C., Bismuth, E., Beltrand, J., Bonnemaison, E., Borot, S., Charpentier, G., Delemer, B., Desserprix, A., Durain, D., Farret, A., Filhol, N., Guerci, B., Guilhem, I., Guillot, C., Jeandidier, N., Lablanche, S., Leroy, R., Melki, V., Munch, M., Penfornis, A., Picard, S., Place, J., Riveline, J. P., Serusclat, P., Sola-Gazagnes, A., Thivolet, C., Hanaire, H., Benhamou, P. Y. (2021). Practical implementation of automated closed-loop insulin delivery: A French position statement. Diabetes & metabolism, 47(3), 101206. https://doi.org/10.1016/j.diabet.2020.10.004
Tubiana-Rufi, N, et al. "Practical implementation of automated closed-loop insulin delivery: A French position statement." Diabetes & metabolism vol. 47,3 (2021): 101206. doi: https://doi.org/10.1016/j.diabet.2020.10.004
Tubiana-Rufi N, Schaepelynck P, Franc S, Chaillous L, Joubert M, Renard E, Reznik Y, Abettan C, Bismuth E, Beltrand J, Bonnemaison E, Borot S, Charpentier G, Delemer B, Desserprix A, Durain D, Farret A, Filhol N, Guerci B, Guilhem I, Guillot C, Jeandidier N, Lablanche S, Leroy R, Melki V, Munch M, Penfornis A, Picard S, Place J, Riveline JP, Serusclat P, Sola-Gazagnes A, Thivolet C, Hanaire H, Benhamou PY. Practical implementation of automated closed-loop insulin delivery: A French position statement. Diabetes Metab. 2021 May;47(3):101206. doi: 10.1016/j.diabet.2020.10.004. Epub 2020 Nov 02. PMID: 33152550.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries